LINACLOTIDE (linaclotide) by Teva is guanylate cyclase activators [moa].
Drug data last refreshed 1mo ago
Guanylate Cyclase Activators
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study of Virtual Reality and Linaclotide for IBS-C
A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
Evaluate the Safety of Linaclotide in IBS-C Patients in China
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Worked on LINACLOTIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Teva is hiring 4 roles related to this product